Latest H5N1 clinical trials Stories
PHILADELPHIA, July 30 /PRNewswire-FirstCall/ -- GlaxoSmithKline (NYSE: GSK) announced today that the U.S. Food and Drug Administration's (FDA) Center for Biologics Evaluation and Research (CBER) has released the first lots of FluLavalÂ® [Influenza Virus Vaccine] allowing distribution in the U.S.
University of Miami researcher uses computer programs to develop a fast and efficient method of generating vaccines for new strains of flu viruses.
ROCKVILLE, Md., July 6 /PRNewswire-FirstCall/ -- Novavax, Inc. (Nasdaq: NVAX) announced today the appointment of Gregory Glenn, M.D., as the company's Chief Scientific Officer who will report to Dr. Rahul Singhvi, President and Chief Executive Officer of Novavax. Previously, Dr.
ROCKVILLE, Md., June 14 /PRNewswire-FirstCall/ -- Novavax, Inc. (Nasdaq: NVAX) announced today the appointments of John W. Madsen, Ph.D., as Head of Process and Manufacturing Operations and Steven Pincus, Ph.D., as Head of Analytical and Quality Operations. Dr.
Researchers at Mount Sinai School of Medicine have developed a new influenza vaccine that brings science one step closer to a universal influenza vaccine that would eliminate the need for seasonal flu shots.
Researchers at Mt. Sinai School of Medicine have developed a novel influenza vaccine that could represent the next step towards a universal influenza vaccine eliminating the need for seasonal immunizations.
ROCKVILLE, Md., May 13 /PRNewswire-FirstCall/ -- Novavax, Inc. (Nasdaq: NVAX) announces the first report of a vaccine protecting ferrets against the 2009 pandemic H1N1 virus has been published in the journal Vaccine May 12, 2010 online issue.
ROCKVILLE, Md., April 29 /PRNewswire-FirstCall/ -- Novavax, Inc.
BETHESDA, Md., April 28 /PRNewswire/ -- LigoCyte Pharmaceuticals, Inc., a private biopharmaceutical company focused on the development of innovative vaccine products, announced today that results from two Phase I studies of its norovirus virus-like particle (VLP) vaccine candidate were presented today at the 13th Annual Conference on Vaccine Research.
ROCKVILLE, Md., April 22 /PRNewswire-FirstCall/ -- Novavax, Inc.
- To give a box on the ear to.